In the last trading session, 1.37 million Tandem Diabetes Care Inc (NASDAQ:TNDM) shares changed hands as the company’s beta touched 1.53. With the company’s per share price at $20.06 changed hands at $0.35 or 1.78% during last session, the market valuation stood at $1.33B. TNDM’s last price was a discount, traded about -167.65% off its 52-week high of $53.69. The share price had its 52-week low at $17.64, which suggests the last value was 12.06% up since then. When we look at Tandem Diabetes Care Inc’s average trading volume, we note the 10-day average is 2.04 million shares, with the 3-month average coming to 1.54 million.
Analysts gave the Tandem Diabetes Care Inc (TNDM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.04. If we narrow down to specifics, the data shows that 1 out of 10 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended TNDM as a Hold, 8 felt it is a Buy and 0 rated the stock as Underweight. Tandem Diabetes Care Inc’s EPS for the current quarter is expected to be -0.6.
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Instantly TNDM was in green as seen at the end of in last trading. With action 12.13%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -44.31%, with the 5-day performance at 12.13% in the green. However, in the 30-day time frame, Tandem Diabetes Care Inc (NASDAQ:TNDM) is -40.07% down. Looking at the short shares, we see there were 7.14 million shares sold at short interest cover period of 4.39 days.
The consensus price target for the stock as assigned by Wall Street analysts is 41.5, meaning bulls need an upside of 51.66% from its current market value. According to analyst projections, TNDM’s forecast low is 22 with 65 as the target high. To hit the forecast high, the stock’s price needs a -224.03% plunge from its current level, while the stock would need to soar -9.67% for it to hit the projected low.
Tandem Diabetes Care Inc (TNDM) estimates and forecasts
Year-over-year growth is forecast to reach 6.22% up from the last financial year.
Consensus estimates given by 18 financial analysts project the company’s revenue in the current quarter to hit an average of 220.19M. 18 analysts are of the opinion that Tandem Diabetes Care Inc’s revenue for the current quarter will be 245.03M. The company’s revenue for the corresponding quarters a year ago was 191.67M and 221.91M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 14.88%. The estimates for the next quarter sales put growth at 10.42%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -28.23%. The 2025 estimates are for Tandem Diabetes Care Inc earnings to increase by 13.45%, but the outlook for the next 5-year period is at 52.59% per year.
TNDM Dividends
Tandem Diabetes Care Inc is expected to release its next quarterly earnings report on 2025-Feb-25.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.85% of Tandem Diabetes Care Inc shares while 110.81% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 111.76%. There are 110.81% institutions holding the Tandem Diabetes Care Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 17.1137% of the shares, roughly 11.12 million TNDM shares worth $448.14 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 11.3518% or 7.38 million shares worth $297.26 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund . With 4.22 shares estimated at $84.74 million under it, the former controlled 6.35% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 3.10% of the shares, roughly 2.06 shares worth around $41.38 million.
